1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Product and Pipeline Analysis of the Global Vaccines Market : Expected Launches in the Areas of Cancer and Allergies Will Drive Growth

  • October 2014
  • 145 pages
  • Frost & Sullivan
Report ID: 2466784

Summary

Table of Contents

Executive Summary

•Vaccines are a class of biologics administered to prevent infectious diseases and reduce mortality and morbidity. It is estimated that vaccines have reduced the incidence of some diseases by more than xx%.
•Vaccines are now available for prevention of about xx infectious diseases.
•Coupled with powerful techniques such as polymerase chain reaction (PCR), mass spectrometry, and next- generation sequencing, the vaccine industry experienced a paradigm shift resulting in innovation and engineering of novel vaccines such as dendritic cell, DNA, and synthetic.
•The vaccine market is segmented into xx categories: infectious disease, cancer, allergy, and others (includes physiological diseases such as diabetes and Alzheimer’s, as well as smoking cessation).
•Infectious disease vaccines—particularly viral vaccines—represent the largest share in terms of products under clinical trial. There is an increased focus on developing vaccines with alternative delivery routes, such as oral and intranasal, to effectively replace the conventional injection method of administration.
•One of the hallmarks of vaccine development is the improved understanding of the immune system. As a result, developers are pursuing vaccines for physiological diseases.
•Developers also are researching vaccines for emerging infectious diseases such as respiratory syncytial virus (RSV), norovirus, human immunodeficiency virus (HIV), Epstein-Barr, malaria, and Leishmaniasis.
•The market is dominated by xxbiopharmaceutical companies—Sanofi, GlaxoSmithKline (GSK), Merck & Co., Pfizer, and Novartis—that combined hold a nearly xx% global market share. The remaining xx% share is fragmented, represented by more than xx companies—the majority of them clinical-stage.
•Many vaccines are in the pipeline in various clinical stages. Successful outcomes are expected to boost the global market at a CAGR of xx% from 2014 to 2022.
•The United States, Europe, and Japan represent the largest markets for vaccine manufacturers; however, with increasing healthcare spending and awareness, emerging regions represent the fastest-growing and attractive markets.
•The vaccine market is perceived as an attractive, profitable venture because of its many opportunities. The overall impact of factors determining profitability is measured in a Porter’s 5 forces analysis.
•While the market is attractive, the intensity of competition is high. It is imperative that companies adopt strategies to meet growing industry demands, such as innovation in or licensing technology platforms for vaccine development or alternative routes toward vaccine administration.
•The vaccine market is witnessing a paradigm shift because of an increasing focus on development of therapeutic vaccines. As a result, the industry is experiencing active collaborations, spin-offs, technological advances, and many active products in the pipeline.

Current Participant Strategies

•Large biopharma corporations’ acquisitions to strengthen their product portfolios in emerging vaccine markets.
•Development of scalable and large-scale manufacturing by outsourcing clinical trials and manufacturing activities.
•Mutually beneficial collaborations and partnerships among companies of all sizes to develop vaccines.

Unmet Needs

•Economical and efficacious prophylactic vaccines in emerging markets.
•Long-term durability of vaccines for HIV, tuberculosis, and other re-emerging diseases.
•New administration routes, such as oral or sublingual.
•Vaccines for physiological disorders and cancer.

Potential Game-changing Strategies

•Technology-dependent development of a new class of vaccines for emerging infectious diseases.
•Development of both prophylactic and therapeutic vaccines to sustain market shares.
•Oral (sublingual, lingual) and needle-free vaccine delivery that increases end-user acceptance.
•Approaches that alleviate safety concerns among end users.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Vaccine Markets in the World to 2021 - Market Size, Development, and Forecasts

  • $ 23395
  • Industry report
  • July 2017
  • by Global Research & Data Services

The expansion of the global vaccine industry is forecast to reach 1.5% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 8.6%. Currently, human vaccines ...

Vaccine Markets in Europe to 2021 - Market Size, Development, and Forecasts

  • $ 12090
  • Industry report
  • July 2017
  • by Global Research & Data Services

The industry report package Vaccine Markets in Europe to 2021 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for vaccines ...

Vaccine Markets in Asia to 2021 - Market Size, Development, and Forecasts

  • $ 9031
  • Industry report
  • July 2017
  • by Global Research & Data Services

The industry report package Vaccine Markets in Asia to 2021 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for vaccines ...


Download Unlimited Documents from Trusted Public Sources

Vaccine Market and Influenza Statistics in India

  • August 2017
    6 pages
  • Vaccine  

    Influenza  

    Diabetes  

  • India  

    United States  

View report >

Anti-Infective Market in the US

  • August 2017
    9 pages
  • Anti-Infective  

  • United States  

View report >

HIV AIDS Statistics and Vaccine Market in the US, Weekly Update

  • August 2017
  • HIV AIDS  

    Infectious Dise...  

    Vaccine  

  • United States  

View report >

Vaccine Market

12 days ago

Related Market Segments :

Vaccine

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.